DPH BEOH Memos
The Wisconsin Bureau of Environmental and Occupational Health (BEOH) program periodically publishes numbered memos to update providers and interested parties of important information. Listed below are memos of interest from those published.
| Memo Number | Description | Issue Date | Attachments | Obsolete date |
|---|---|---|---|---|
|
BEOH 2024-01 |
New Recommendation for Universal Blood Lead Testing of Children | |||
|
BEOH 2022-02a |
La certificación provisional para los solicitantes individuales dura ahora hasta que se emita la tarjeta de certificación | |||
|
BEOH 2022-02 |
Provisional Certification for Individual Applicants Now Lasts Until Certification Card Issued | |||
|
BEOH 2022-01 |
Exterior Lead Abatement and Renovation Cleaning Activities: Wet/Dry Vacuum with HEPA Filter and Drywall Bag is OK | |||
|
BEOH 2021-04 |
New CDC Blood Lead Reference Value of 3.5 Micrograms per Deciliter (µg/dL) for Children | |||
|
BEOH 2021-03a |
Se aceptan copias electrónicas o impresas como prueba de certificación de la certificación en el sitio | |||
|
BEOH 2021-03 |
Electronic or Printed Copies of Certification Acceptable As On-Site Proof of Certification | |||
|
BEOH 2021-02 |
Initial Asbestos Worker Course Test Option for Students Who Fail Initial Asbestos Supervisor Course Test | |||
|
BEOH 2021-01 |
Public Health Follow-up of Suspected Cases of Infant Methemoglobinemia | |||
|
BEOH-2019-04 |
Severe Pulmonary Disease Among Persons Who Reported Vaping | |||
|
BEOH 2019-03 |
New Case of Severe Bleeding Associated with Synthetic Cannabinoid ("K2" and "Spice") Use | |||
|
BEOH 2019-02 |
Severe Pulmonary Disease Among Adolescents Who Reported Vaping | |||
|
BEOH-2019-01 |
Blue-Green Algae (Cyanobacteria) and Cyanotoxin Poisoning Reporting Requirements | |||
|
BEOH 2018-05 |
Carbon Monoxide Poisoning Reporting Requirements | |||
|
BEOH 2018-04 |
New Environmental and Occupational Reportable Conditions | |||
|
BEOH 2018-03 |
Guidance for EMS: Severe Bleeding Continues Among Synthetic Cannabinoids (“K2” and “Spice”) Users | |||
|
BEOH 2018-02 |
Guidance for Clinicians: Severe Bleeding Continues Among Synthetic Cannabinoids (“K2” and “Spice”) Users | |||
|
BEOH 2018-01 |
Guidance for Pharmacists: Severe Bleeding Continues Among Synthetic Cannabinoids (“K2” and “Spice”) Users |